Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Provide Patented DehydraTECH(TM) to Cannadips’ Cannabis Products in California and Across the US

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has reached a new definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips’ cannabis products, both in its current California market and across the United States. According to the update, Lexaria’s DehydraTECH fast-acting, high-absorption technology is perfectly suited to improve consumer satisfaction and the dipping experience. Terpene-rich multi spectrum oils are base ingredients of Cannadips THC, and DehydraTECH is able to reduce throat irritation normally associated with some terpenes. Inferior products utilize less efficacious cannabis isolate without terpenes that lack the entourage effect derived from multi-spectrum oils in an attempt to get around this problem. “Lexaria is building a stronger relationship with the Cannadips brand and applying DehydraTECH to Cannadips cannabis represents our latest advance,” Lexaria Bioscience CEO Chris Bunka stated in the news release. “Our DehydraTECH technology empowers a scalable supply chain across state lines for our cannabis brand licensees. We are excited that Cannadips is interested in activating the Lexaria technology in additional key state markets that are either recreational or medical cannabis states, while preserving the brand rights as states come online through regulation.”

To view the full press release, visit http://cnw.fm/4qN9T

About Lexaria Bioscience Corp.

Lexaria Bioscience is a global innovator in drug-delivery platforms. The company’s patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Grapefruit Boulevard Investments, Inc. (IGNG) Files Amendment No. 1 to Registration Statement

Grapefruit Boulevard Investments (“GBI”), a licensed and fully compliant California based cannabis distribution and manufacturing company and a wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG) (collectively “Grapefruit”), this morning announced that it has filed Amendment No. 1 to its Registration Statement on Form S-1 that was originally filed on July 28, 2019 regarding conversions of convertible notes issued to the company’s institutional investor Auctus Fund, LLC. “We are very pleased to file the Amendment which puts us back on track to complete the Auctus transaction. Pursuant to the terms of our Agreements with Auctus, immediately upon effectiveness of the Registration Statement, which we believe should occur in late February of 2020 we will receive a new Convertible Note Tranche of $750,000.00 from Auctus and 90 days later a final Convertible Note Tranche of $1,000,000.00. These funds are key to our revenue growth in 2020. In addition, as our common stock price increases in the future, we will be able to call warrants to bring in additional working capital. We are currently focused on ramping up revenues to justify an increased stock price which will afford us the opportunity to call the Warrants. We are also in the process of evaluating other capital raising possibilities. We feel we have regained our momentum which was temporarily slowed by the delay in the Grapefruit Boulevard Investment audit and look forward to 2020 and the myriad possibilities the future holds for Grapefruit,” Grapefruit CEO Bradley J. Yourist stated in the news release.

To view the full press release, visit http://cnw.fm/DEBv5

About Grapefruit Boulevard Investments Inc.

Grapefruit is a wholly-owned subsidiary of Imaging3, Inc. Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 14 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis company. For more information, visit the company’s website at www.Grapefruitblvd.com.

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://cnw.fm/IGNG

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Missouri Judge Orders Delay in Issuing Medical Marijuana Dispensary License

On Friday evening, the Missouri Department of Health and Senior Services was ordered by a court in Missouri to delay the approval or rejection of one applicant who had applied for a license to run a medical marijuana dispensary.

According to the statement previously issued by the Health Department, the permits would enable businesses located in secure areas to sell medical cannabis to patients. The Department expected to issue a minimum of 192 licenses within the state by January 24.

Judge Daniel Green, with the Cole County Circuit Court, ordered the delay of approval or rejection of one applicant for a license in Independence until a week (Jan.27) after the initial decision date.

It is not yet clear how the delay will affect the whole licensing process. When asked about the court order on Saturday morning, a DHSS spokeswoman said via a text message that the case is not about DHSS, but about the Independence ordinance. She further said that she does believe that the process would be delayed but asked them to refer their questions to the Office of the Attorney General in Missouri.

No response was issued by the spokesman for the attorney general when contacted for a comment.

At the beginning of last week, the USA TODAY Network reported that in 2019, Independence approved cannabis zoning rules were stricter than the barriers in churches, daycares, and schools that are written in the state-level medical cannabis constitutional amendment.

A former owner of a marijuana clinic that specialized in patients seeking state-approved medical marijuana cards Emily Branch said that supporters of marijuana regard Independence zoning rules as a violation of the Missouri constitution.

According to public records, the plaintiff, in this suit is the HCKC LLC, which is operating as Healing Center of Kansas City.

One of the officials of the Healing Center, Jay Richards, said that the company would not issue any statement at the time, but maybe after the state awards them the dispensary permit.

According to the medical marijuana dispensary applicant record provided by the Missouri Department of Health, there were other companies tied to Healing Center that applied for at least ten licenses.

Healing Center retail outlets would be spread across the state to St. Louis, Kansas City areas, Rolla, and Columbia.

Lying at the center of the lawsuit is the dispensary to be opened in the Kansas City Area, which is the hometown of President Harry Truman.

The suit’s defendants include the City of Independence, Department of Health and Senior Services, and its director Randal Williams, and they are using the same lawyer for their defense.

Another lawsuit was filed against the DHSS by the Sarcoxie Nurseries Tree Farm, who were denied a commercial cultivation license. At the beginning of January, the owner of Medigro LLC, Brian Atchley, said that he is tied to the two lawsuits. And like many other permit applicants, Atchley is questioning the DHSS licensing protocols.

Industry experts say such lawsuits can potentially derail the roll-out of the marijuana program, and they are certain that industry actors like No Borders Inc. (OTC: NBDR) wouldn’t want such a barrier to persist for long.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Oregon Report Shows Recreational Weed Sales Are Highest Along Idaho Border

The Oregon Office of Economic Analysis released a report which showed that marijuana sales are most substantial along the Oregon border with Idaho. It is noteworthy that recreational marijuana is illegal in the state of Idaho, so residents who wish to consume it have to buy it from Oregon.

According to the report which was issued on Friday, adult marijuana sales along the border of Oregon and Idaho are 420% the statewide average, wrote Josh Lehner of the Oregon Office of Economic Analysis. It is ironical that the percentage is 420 since that also happens to be the colloquial term for weed!

Along the Borders of Idaho and Washington, Lehner also found that marijuana sales were high. Recreational marijuana is legal in Washington.

Lehner further wrote that marijuana sales along the cities neighboring Idaho were stronger than he had anticipated. Recreational marijuana is illegal in the state of Idaho; however, after using a tax model to account for incomes, number of retailers, and tax rates, they found that there was a vast border effect.

A border effect occurs when two neighboring states have different rules, which prompt the residents of one jurisdiction to travel to the other in order to experience and take advantage of the different regulations in the other state. For instance, residents of Idaho traveling to Oregon to consume recreational marijuana. Another example is where the residents of Southwest Washington travel to Oregon to buy products on which no sales tax is levied.

In the U.S., Idaho is one of the few states without a law regulating medical marijuana, said the Marijuana Policy Project. Marijuana advocates working with the Idaho Cannabis Coalition and supporters, are collecting signatures to legalize medical marijuana within the state. This will make it possible for the residents of Idaho to legalize medical marijuana through a ballot initiative in November.

Lerner also forecasted that if the border effects persist in the next ten years, Oregon is going to experience rapid growth in marijuana sales.

Lehner further wrote that his office predicts that during the next ten years, the state’s marijuana sales are going to increase as incomes increase, the population within the state also increases, and as the stigma surrounding marijuana dies and the consumption rate rises.

The petition for gathering signatures was approved in August of 2019, and the advocates and supporters must collect more than 55,000 signatures within the state of Idaho to qualify for the 2020 ballot. April 30, 2020, is the deadline for signature collection.

After filing the petition, the leader of the campaign, Bill Esbensen, said that people should not suffer because they live in the wrong state. He also noted that the medical marijuana initiative is to bring Idaho up to par with other states where medical marijuana is legal such as Oklahoma, Arkansas and West Virginia. This will enable patients to treat their medical conditions with a non-toxic plant.

Analysts believe that weed companies like SinglePoint Inc. (OTCQB: SING) may be thinking that Oregon marijuana companies are getting some respite from the glut as a result of the border effect and this buys them some more time to build a bigger customer base within the state.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Namaste Technologies Inc.’s (TSX.V: N) (OTCQB: NXTTF) Position to Capitalize on Changing Cannabis Industry Highlighted in technical420 Article

Namaste Technologies (TSX.V: N) (OTCQB: NXTTF), an online platform for cannabis products, accessories, and responsible education, was highlighted in a recent article by Anthony Varrell on technical420 titled ‘Namaste Technologies Is On Track To Be One Of The Biggest Turnaround Stories of 2020’. Among other highlights, the article discusses some recent key achievements by the company as well as its strategy moving forward. “Through CannMart, Namaste is well positioned to capitalize on the cannabis 2.0 opportunity, and we find this to be significant. The company expects to start selling several new cannabis derivative products in March and to submit up to 11 unique product SKUs to Health Canada for approval,” author Anthony Varrell states in the article. “The new product formats will be available on CannMart.com and offered through provincial cannabis stores in authorized markets.”

To view the full article, visit http://cnw.fm/doZY0

About Namaste Technologies

Namaste Technologies is the world’s leading online platform for cannabis products, accessories, and responsible education. The company is comprised of a number of wholly owned subsidiaries that could present significant upside and we are favorable on value creation that Namaste could deliver through this portfolio. CannMart represents one of the most important aspects of the Namaste story and the company believes that the market does not fully appreciate the value associated with this opportunity. CannMart provides customers with a diverse selection of hand-picked products from leading Canadian Licensed Producers (LPs). For more information, visit www.NamasteTechnologies.com.

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

HempNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries, Inc. Secures $1.2M of Tolling Revenue for February

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp enterprise, together with its wholly owned subsidiary, Khrysos Industries, Inc., today announced that its tolling operation within its 82,000 square foot facility in Orlando, Florida has filled 42% of its available capacity generating $1.2 million of revenue for February tolling production. According to the update, Khrysos Industries tolling operation represents one revenue segment of Youngevity’s hemp enterprise. “Our current capacity for our tolling operations, at current prices, provides us the opportunity to generated monthly revenue of approximately $3 million per month,” YGYI President and CFO Dave Briskie said in the news release. “Currently, we are seeing strong demand for tolling of crude oil and we anticipate that this will continue throughout 2020. We remain committed to our hemp enterprise and its fully vertical capabilities in ingredient production, tolling, extraction and processing equipment sales, and finished goods and packaging.”

To view the full press release, visit http://cnw.fm/dL6hT

About Youngevity International, Inc.

YGYI, Inc. (NASDAQ: YGYI), is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution(R) Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

HempNewsBreaks – MCTC Holdings, Inc. (MCTC) Enters Distribution Contract with Marijuana Company of America for Hemp You Can Feel(TM)

MCTC Holdings (OTC: MCTC), a cannabinoid science forward company developing unique infusion technologies and cannabinoid delivery systems, today announced its entry into a distribution contract with Marijuana Company of America (OCTQB: MCOA) for MCTC’s Hemp You Can Feel(TM) beverage product line. According to the update, the patent-pending, ultra-clean label beverage line is 95% organic and consists of hemp extract and CBD powdered drink mixes, including soft drinks and non-alcoholic cocktail mixers. “We are pleased to be providing our products for the HempSMART line from Marijuana Company of America,” MCTC Holdings CEO Arman Tabatabai said in the news release. “We share the same beliefs relative to product labeling and we both are proud of this drink line, which is based on 95% organic ingredients and hemp extract infusions containing only natural ingredients. While we are starting out with powdered soft drink mixes, we plan to expand to the other drink offerings that we plan to introduce soon.”

To view the full press release, visit http://cnw.fm/vhk1Y

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. More information on the Company can be viewed at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About HempWireNews

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

420 with CNW – Illinois Weed Shops Grapple With Staff Shortages Amidst High Product Demand

Apart from the weed shortage in Illinois, marijuana shops are also experiencing a shortage of state-approved employees who can work behind the counter since the sale of marijuana was launched on January 1.

Due to a current marijuana shortage, some of the marijuana shops selling adult-use marijuana have closed shop or reduced their sale hours. Others, such as Cresco Labs and PharmaCann, closed their shops on Monday to give their employees a much-deserved break after working five days of long shifts. The shops did not close due to the weed shortage.

On Saturday, the spokesman for Cresco Labs, Jason Erkes, said that the company leaders were working cash registers because they did not have enough employees.

On New Year’s Day, the CEO of Green Thumb Industries, Ben Kovler, was working behind the counter at the company’s Rise dispensary located in Mundelein.

Before the launch of marijuana sales on January 1, marijuana shops knew they had to increase their workforce to manage the enormous number of recreational customers. However, many of the employees have not been able to start working because the Department of Financial and Professional Regulation in Illinois has not issued them with the required identification cards.

On Wednesday, the Illinois Department of Financial and Professional Regulation issued a statement saying that it had issued approximately 2,000 marijuana dispensary agent cards. The department received an influx of new applications from people looking to work in the recreational industry ahead of January 1, when the program was set to be launched.

The department is working round the clock to make sure that they are within the statutorily mandated timeframe in processing the applications. The Department Of Financial and Professional Regulation is performing background checks on all the applicants to ensure that they meet the licensing requirements.

Although marijuana companies are reluctant to criticize the IDFPR, they have discussed the staffing challenges with the state officials.

Marijuana companies are extra strict on security because of the fears expressed by the lawmakers about crime associated with the illicit marijuana market industry. The shortage of state-approved marijuana employees has been a challenge since the onset of marijuana sales in Illinois.

A cannabis industry veteran from the state of Colorado who has been involved in the marijuana business in several other states, Kayvan Khalatbari, said that in Ohio, it could take nearly two months before the state approves an employee. He further noted that since the launch of marijuana on January 1, employees have been working crazy hours, and marijuana shop owners have been seen doing jobs they are not used to. This has contributed to the slow turnaround time for serving customers, which has been a real hindrance to businesses.

Experts say that for the sake of stability and future growth of the Illinois weed industry, companies like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) are hoping that the employee and product shortages are resolved soon so that consumers aren’t forced to resort to the illicit market.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – CMC Urges UK Government to Rethink Medical Marijuana Policy

On Wednesday, the Centre for Medicinal Cannabis (CMC) requested the United Kingdom government to perform an urgent review of the medical marijuana policy regarding marijuana accessibility.

The request came after the CMC published the findings of a UK survey. The poll investigated the general public consumption frequency of street-available marijuana in England, Wales, and Scotland.

The YouGov survey had 10,602 respondents, and the study findings were published in a new report referred to as ‘Left Behind-The Scale of Illegal Cannabis Use for Medicinal Intent’. According to the survey findings, more than 1.4 million people (2.8% of the adults) are treating chronic health conditions with marijuana.

The report also revealed that people across all age groups, social standing, family groups, and both sexes from Britain are using marijuana therapeutically, and half of them spend approximately £100 every month on weed to manage their symptoms.

After analyzing the survey findings, CMC made the following estimation on the number of people using marijuana to treat various health conditions in the UK.

Depression – 653,456
Anxiety – 586,288
Chronic pain – 326,728
Arthritis – 230,631
Insomnia – 182,583
Post-traumatic stress disorder (PTSD) – 177,778

The medical lead at the Center for Medicinal Cannabis, Dr. Daniel Couch, said that the data in their report highlights the personal, moral, and societal cost of consuming street-available weed.

According to the published report, marijuana consumption is done by people across all socio-demographic groups. Self-medicating on medical marijuana was observed in 56% of people from social class C2DE, and 44% from ABC1.

The majority of the people who are self-medicating are between the ages of 18-44 ( 71.4%); however, a large number of users are above the age of 55 (14.6%), while 80% of these people use marijuana as a treatment daily or weekly.

On the issue of consumption frequency, the survey found that daily, weekly, and monthly use was 55.8%, 23.4%, and 8.5%, respectively. It also found that 42% of consumers spend more than £100 each month on street marijuana while 9% of consumers do not spend a penny on weed because they either grow it or are given by friends or caregivers.

The highest spending was observed among people who have Parkinson’s disease as they spent £350 each month.

According to the poll’s findings, people are using marijuana to treat the following conditions:

Depression,
Anxiety,
Chronic pain,
Insomnia,
Autism spectrum disorder,
Psoriasis,
High blood pressure,
Cancer,
Schizophrenia,
Spinal cord injury,
Glaucoma,
Heart disease,
Cascular disease,
Peripheral neurosis, and
HIV/AIDs.

According to the YouGov survey, the consumption frequency of people suffering from various ailments was as follows, Huntington’s disease 41.67%, schizophrenia, 41.18%, Parkinson’s disease 30.43%, Autism spectrum disorder 20.39%, Multiple Sclerosis 19.23%, and PTSD 17.37%.

The review on medical marijuana policy called for by the CMC is intended to ensure that patients can afford marijuana as well as reducing the personal risk of buying street-available weed.

Currently, the number of clinical trials assessing the therapeutic effect of marijuana-based medicines is limited.

The founder of the Center for Medicinal Cannabis, Steve Moore, said that the survey findings confirm their suspicion that at least 3% of the adult population in the UK are using marijuana to manage their chronic health conditions instead of the pharmaceutical products.

The report reaffirms the importance of re-evaluating the issue of marijuana accessibility in the UK, said the Ceo of Block Commodities, Ian Tordoff. Tordoff further noted that his company would continue to support CMC efforts and raise awareness of the positive impact of marijuana plants on public health and general social wellbeing.

Industry watchers believe that cannabis companies like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) are always deeply saddened when reports of entire populations forced to depend on marijuana from the black market emerge as this UK survey shows.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – SinglePoint Inc. (SING) Debuts New Line of JTI USA’s PrimeTime Little Cigars at 2019 MJBIZCON

SinglePoint (OTCQB: SING) recently entered into a distribution agreement with JTI USA, a multibillion-dollar organization with an international presence in 130 countries (http://cnw.fm/fFn79). An article discussing the company reads, “In addition to debuting the 1606 Original Hemp pre-rolled product, SING will represent — and take orders for — JTI’s PrimeTime Little Cigars debut. This product has already become known as the ‘best-flavored little cigars’ on the market. PrimeTime(TM) has built a reputation as a leading consumer over the last 20 years and has been in major accounts such as Circle K and 7-Eleven. . . . ‘I’m excited and honored to be working with JTI to distribute PrimeTime Little Cigars,’ SING CEO Greg Lambrecht stated in a news release. ‘The opportunity to work with a global leader in this category is exciting, and we are ready to expand Primetime’s U.S. market share with our unique experience in alternative markets. Having placed premium cigars in over 20,000 accounts, we expect this opportunity to be one of our major revenue sources in coming years, and to distribute additional JTI products as we grow this category.’”

To view the full article, visit http://cnw.fm/L5NZe

About SinglePoint Inc.

SinglePoint invests in and acquires brands and companies that will benefit from an injection of growth capital and sales and marketing expertise. The company’s portfolio currently includes solar, hemp and distribution tobacco products. SinglePoint is working to grow the company to a multinational brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.